APPLICATION OF MONOCLONAL ANTIBODY-BASED LATEX AGGLUTINATION TEST FOR DETECTION AND IDENTIFICATION OF THE AGENT OF MELIOIDOSIS IN CLINICAL AND ENVIRONMENTAL OBJECTS

Cover Page


Cite item

Full Text

Abstract

The review summarizes the basic information on the development and diagnostic capabilities of the latex agglutination test (LAT), used for detection and subsequent identification of melioidosis pathogen. According to the published literature, the use of melioidosis monoclonal antibodies of various epitope direction for coat the latex beads (suspension carrier), the main detection ingredient of this reaction, contributes to an increase in the diagnostic capabilities of this method: its sensitivity and specificity, which has been repeatedly confirmed by specialists working both in endemic zone distribution of Burkholderia pseudomallei and outside these territories. As most authors of the publications noted, after introduction of this reaction into practical work of profile laboratories, low-cost commercial products (test set of reagents for latex agglutination reaction) can find wide application both in stationary and mobile laboratories. The undoubted merits of the method are its simplicity, clarity, suitability for working with various samples from objects of the external environment and biological material, as well as obtained evidence ofthe suitability of LAT to ensure effective differentiation of B. pseudomallei from avirulent related bacteria and detection of the causative agent in the early stages of the disease for relatively short intervals, which makes it a promising method for diagnosing melioidosis, a potentially fatal infection requiring an early onset appropriate antibiotic therapy.

About the authors

N. P. Khrapova

Volgograd Research Institute for Plague Control

Author for correspondence.
Email: noemail@neicon.ru
Russian Federation

L. K. Merinova

Volgograd Research Institute for Plague Control

Email: noemail@neicon.ru
Russian Federation

T. V. Zamarina

Volgograd Research Institute for Plague Control

Email: noemail@neicon.ru
Russian Federation

D. M. Frolov

Volgograd Research Institute for Plague Control

Email: noemail@neicon.ru
Russian Federation

T. V. Senina

Volgograd Research Institute for Plague Control

Email: noemail@neicon.ru
Russian Federation

I. I. Korsakova

Volgograd Research Institute for Plague Control

Email: noemail@neicon.ru
Russian Federation

References

  1. Илюхин В.И., СенинаТ.В., Плеханова Н.Г., Антонов В.А., Меринова Л.К., Сеимова И.К. Burkholderia thailandensis: биологические свойства, идентификация и таксономическая позиция. Мол. генет., микробиол. и вирусол. 2002, 1:7-11.
  2. Лабораторная диагностика опасных инфекционных болезней. Практическое руководство. Г.Г.Онищенко, В.В.Кутырев (ред.). М., ЗАО «Шико», 2013.
  3. Специфическая индикация патогенных биологических агентов: Практическое руководство. Г.Г.Онищенко, В.В.Кутырев (ред.). Саратов, ООО «Буква», 2014.
  4. Amomchai Р., Chierakul W., Wuthiekanun V. et al. Accuracy of Burkholderia pseudomallei identification using the API 20NE system and a latex agglutination test. J. Clin. Microbiol. 2007,45 (11): 3774-3776.
  5. Anuntagool N., Naigowit P, Petkanchanapong V. et al. Monoclonal antibody-based rapid identification of Burkholderia pseudomallei in blood culture fluid from patients with community-acquired septicaemia. J. Med. Microbiol. 2000,49 (12): 1075-1078.
  6. Anuntagool N., IntachoteP,WuthiekanumV.etal. Lipopolysaccharide from nvirulent Ara+ Burkholderia pseudomallei isolates in immunologically indistinguishable from lipopolysaccharide from virulent Ara' clinical isolates. Clin. Diagn. Lab. Immunol. 1998, 5 (2): 225-229.
  7. Anuntagool N., Intachote P., Naigowit P et al. Rapid antigen detection assay for identification of Burkholderia (Pseudomonas) pseudomallei infection. J. Clin. Microbiol. 1996, 34 (4): 975976. ,.
  8. Anuntagool N., Panichakul T, Aramsri P. et al. Shedding of lipopolysaccharide and 200-kDa surface antigen during the in vivo growth of virulent Ara- and avirulent Ara+ Burkholderia pseudomallei. Acta. Trop. 2000, 74 (2-3): 221-228.
  9. Bossi P, Guihot A., Bricare F. Emerging or re-emerging infections that can be used for bioterrorism. Presse Med. 2005, 34 (2 Pt 2): 149-155.
  10. Chaowagul W., White N.J., Dance D.A. et al. Melioidosis: a major cause ofcommunity acquired septicemia in northeastern Tailand. J. Infect. Dis. 1989,159 (5): 890-899.
  11. Currie B.J., Dance D.A., Cheng A.C. The global distribution of Burkholderia pseudomallei and melioidosis: an update. Trans. R. Soc. Trop. Med. Hyg. 2008, 102 (1): 1-4.
  12. Currie B.J., Fisher D.A., Howard D.M. etal. Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin. Infect. Dis. 2000, 31 (4): 981986.
  13. Dance D.A. Melioidosis as an emerging global problem. Acta. Trop. 2000, 74 (2-3): 115119.
  14. DharakulT., Songsivilai S., SmithikarnS. et at Rapid identification of Burkholderia pseudomallei it blood aulfuans by latex agglutinating using lipnpnlysacaOpaide-spnaifia mngnalngrl anfibody. Am. J. Taop. Med. Hyg. 1999,61 (4): 658-662.
  15. Duval U.D., Elaod M.G., Gee J.E. ef al. Evaluating of a lafex agglutination assay for the identification Burkholderia pseudomallei and Burkholderia mallei. Am. J. Taop. Med. Hyg. 2014, 90 (6): 1043-1046.
  16. Ekpo a, Rungpania O U., Pongsunh 0. ef al. Use of protein-specific monoclonal antibody-based lafex agglutination for rapid diagnosis of Burkholderia pseudomallei infeation in patienfs with community-acquired septiaemia. Clin. Vaccine Immunol. 2007,14 (6): 811-812.
  17. Gilad J., Schwartz D., Amsalem Y. Сlinical feptuaes and laboratory diagnosis of infeation with the potential bioterrorism agents Burkholderia mallei and Burkholderia pseueompllei. Inf. J. Uiomed. Oai. 2007, 3 (3): 144-152.
  18. Inglis T.J., Mearritt A., Chidlow G. ef al. Comparison of diagnostic laboratory methods for identification of Burkholderia pseudomallei. J. Clin. Miaanbiol. 2005,43 (5): 2201-2206.
  19. Jedudason M.V., Balaji V, Sirisinha S. ef al. Rapid idenfification of Burkholderia pseudomallei in blood culture supernatants by a coagglutination assay. Clin. Miaaobiol. Infeaf. 2005,11: 925-936.
  20. Khan A.O., Levitt A.M., Oage M.J. Biological and chemical terrorism: strategic plan for pae-paredness and response. MMWR Reaomm. Rep. 2000,49 (RR-4): 1-14.
  21. Lau S.K., Sridhar So Ho C.C. et al. Laboratory diagnosis of melioidosiss:past, present and future. Exp. Uiol. Med. 2015, 240: 742-751.
  22. Pongsunk S., EkpoP., Dharakul T. Production of specific monoclonal antibodies fo Burkholderia pseudomallei and their diagnostic application. Asian Рас. J. Alleagy Immunol. 1996, 14 (1): 43-47.
  23. Pongsunk S., Thirawattanasuk N. Piyasangthong N. et.al. Rapid identifiaction Burkholderia pseudomallei in blood cultures by a monoalonal antibody assay. J. Clin. Miaaobiol. 1999, 37 (11): 3662-3667.
  24. Samosornsuk N., Lulitanond A., Saenla N. et. al. Shot report: evalution of a monoclonal antibody-based latex agglutination test for rapid diagnosis of septicemia melioidosis. Am. J. Taop. Med. Hyg. 1999, 61 (5): 735-737.
  25. Sirisinha S., Anuntagool N., Intachote P. J. et al. Antigenic differences between clinical and enviromental isolates of Burkholderia pseudomallei. Miaaobiol. Immunol. 1998, 42 (11): 731-737.
  26. Sirisinha S., Anuntagool N., Dharakul T. et al. Recent developments in laboratory diagnosis of melioidosis. Aafa Taop. 2000, 74 (2-3): 235-245.
  27. Smith M.D., Wuthiekanun V, Walsh A.L. et al. Latex agglutination test for identification of Pseudomonas pseudomallei. J. Clin. PatOol. 1993,46: 374-375.
  28. Smith M.D., Angus U.J., Wuthiekanun V. et al. Arabinose assimilation defines a nonviaulent biofyae of Burkholderia pseudomallei. Infeaf. Immun. 1997, 65 (10): 4319-4321.
  29. Steinmetz I., Reganzerowski A., Brenneke U. et al. Rapid identifiacation of Burkholderia pseudomallei by latex agglutination based on an exopolyspaccharide-specific monoclonal antibody. J. Clin. Miaanbiol. 1999, 37 (1): 225-228.
  30. Thephai C., Dharakul T, Smithikarn O. et al. Differentiation between non-virulent and virulent Burkholderia pseudomallei with monoclonal antibodies to the Ara+ and Ara- biotypes. Am. J. Taop. Med. Hyg. 2001, 65 (1): 10-12.
  31. White N.J., Dance D.A., Chaowagul W. et al. Halving of mortality of severe melioidosis by ceftazidime. Lpnaet. 1989, 2 (8665): 697-701.
  32. Wuthiekanun V., Anuntagool N., White N. et al. Shot report: a rapid method for the differentiation of Burkholderia pseudomallei and Burkholderia yhailandensis. Am. J. Taop. Med. Hyg. 2002, 66 (6): 759-761.
  33. Wuthiekanun V, Desakorn V, Wongsuvan G. et al. Rapid immunofluoaescenae microscopy for diagnosis of melioidosis. Clin. Diag. Lab. Immunol. 2005, 12: 555-556.
  34. Wuthiekanun V, Smith M.D., Dance D.A. et al. Biochemical characteristics of clinical and environmental isolates of Pseudomonas pseudomallei. J. Med. Miaanbiol. 1996, 45: 408412.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Khrapova N.P., Merinova L.K., Zamarina T.V., Frolov D.M., Senina T.V., Korsakova I.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies